Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;55(3):319-26.
doi: 10.1136/gut.2005.070011. Epub 2005 Aug 16.

Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus

Affiliations

Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus

S Bruley des Varannes et al. Gut. 2006 Mar.

Abstract

Background and aims: Achalasia is a disease of unknown aetiology. An immune mechanism has been suggested on the basis of previous morphological observations. The objective of this study was to test whether the serum of achalasia patients could reproduce the phenotype and functional changes that occur with disease progression in an ex vivo human model.

Methods: Specimens of normal human fundus were maintained in culture in the presence of serum from patients with achalasia, gastro-oesophageal reflux disease (GORD), or healthy subjects (controls). Immunohistochemical detection of choline acetyltransferase (ChAT), neurone specific enolase (NSE), vasoactive intestinal polypeptide (VIP), nitric oxide synthase (NOS), and substance P was carried out in whole mounts of gastric fundus myenteric plexus. In addition, the effects of achalasia serum on electrical field stimulation (EFS) induced contractions were measured in circular muscle preparations.

Results: Serum from achalasia patients did not affect the number of myenteric neurones. Tissues incubated with serum from achalasia patients showed a decrease in the proportion of NOS (-26% of NSE positive neurones; p=0.016) and VIP (-54%; p=0.09) neurones, and a concomitant increase in ChAT neurones (+16%; p<0.001) compared with controls. In contrast, GORD serum did not modify the phenotype of myenteric neurones. Area under the curve of EFS induced relaxations (abolished by N-nitro-L-arginine methyl ester) was significantly decreased following incubation with serum from achalasia patients compared with controls (-7.6 (2.6) v -14.5 (5.0); p=0.036).

Conclusions: Serum from achalasia patients can induce phenotypic and functional changes which reproduce the characteristics of the disease. Further identification of putative seric factors and mechanisms involved could lead to the development of novel diagnostic and/or therapeutic strategies in achalasia.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment in

Similar articles

Cited by

References

    1. Sifrim D, Janssens J, Vantrappen G. Failing deglutitive inhibition in primary oesophageal motility disorders. Gastroenterology 1994106875–882. - PubMed
    1. Mearin F, Papo M, Malagelada J R. Impaired gastric relaxation in patients with achalasia. Gut 199536363–368. - PMC - PubMed
    1. Robertson C S, Martin B A B, Atkinson M. Varicella‐zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 199334299–302. - PMC - PubMed
    1. Mearin F, Mourelle M, Guarner F.et al Patients with achalasia lack nitric oxide synthase in the gastro‐oesophageal junction. Eur J Clin Invest 199323724–728. - PubMed
    1. De Giorgio R, Di Simone M P, Stanghellini V.et al Oesophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol 1999942357–2362. - PubMed

MeSH terms